Free Trial

Kymera Therapeutics (KYMR) Insider Trading & Ownership

Kymera Therapeutics logo
$85.34 -0.74 (-0.86%)
As of 01:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Kymera Therapeutics (NASDAQ:KYMR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
15.98%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$215.30M
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$83.71M
Get KYMR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kymera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KYMR Insider Buying and Selling by Quarter

Kymera Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/29/2026Sell30,000$81.18$2,435,400.00  
4/22/2026
Bruce Booth
Bruce Booth
Director
Sell5,900$89.96$530,764.00  
4/22/2026
Bruce Booth
Bruce Booth
Director
Sell100$90.08$9,008.00  
4/22/2026Sell300$90.00$27,000.00  
4/15/2026
Bruce Booth
Bruce Booth
Director
Sell2,200$89.95$197,890.00  
4/15/2026
Bruce Booth
Bruce Booth
Director
Sell3,135$90.10$282,463.50  
4/15/2026Sell1,300$90.00$117,000.00  
4/14/2026
Bruce Booth
Bruce Booth
Director
Sell4,159$89.97$374,185.23  
4/14/2026Sell5,251$90.00$472,590.00  
4/14/2026Sell1,347$90.00$121,230.00  
4/10/2026Sell2,000$87.35$174,700.00  
4/9/2026Sell8,264$87.50$723,100.00  
4/1/2026Sell4,600$85.42$392,932.00  
4/1/2026Sell14,640$85.46$1,251,134.40  
3/31/2026Sell7,400$85.37$631,738.00  
3/31/2026Sell7,600$85.38$648,888.00  
3/25/2026Sell24,727$80.26$1,984,589.02  
3/23/2026Sell91,250$77.41$7,063,662.50  
3/11/2026Sell25,758$83.30$2,145,641.40  
3/4/2026Sell4,895$85.30$417,543.50  
3/4/2026Sell4,895$85.30$417,543.50  
3/4/2026Sell3,919$85.30$334,290.70  
3/2/2026
Bruce Booth
Bruce Booth
Director
Sell81,866$90.13$7,378,582.58  
3/2/2026Sell7,576$88.93$673,733.68  
3/2/2026Sell5,613$88.93$499,164.09  
3/2/2026Sell2,039$88.93$181,328.27  
2/25/2026Sell30,000$90.26$2,707,800.00  
12/31/2025Sell30,000$78.06$2,341,800.00  
12/12/2025
Bruce Booth
Bruce Booth
Director
Sell678$91.04$61,725.12  
12/11/2025
Bros. Advisors Lp Baker
Director
Buy2,005,813$86.00$172,499,918.00  
12/11/2025
Bruce Booth
Bruce Booth
Director
Sell6,101$91.23$556,594.23  
12/10/2025
Bruce Booth
Bruce Booth
Director
Sell229,809$91.73$21,080,379.57  
12/8/2025Sell49,307$88.67$4,372,051.69  
12/8/2025Sell5,000$89.76$448,800.00  
12/8/2025Sell100,000$89.17$8,917,000.00  
10/29/2025Sell30,000$60.99$1,829,700.00  
10/15/2025Sell59,576$61.42$3,659,157.92  
10/13/2025Sell3,114$60.00$186,840.00  
10/13/2025Sell5,000$59.19$295,950.00  
9/17/2025Sell79,220$50.00$3,961,000.00  
9/16/2025Sell30,000$49.00$1,470,000.00  
6/30/2025
Bros. Advisors Lp Baker
Director
Buy655,500$44.00$28,842,000.00  
6/30/2025
Bvf Partners L P/Il
Director
Buy317,167$44.00$13,955,348.00  
6/3/2025Sell12,000$46.10$553,200.00  
6/3/2025Sell6,349$49.00$311,101.00  
6/3/2025Sell30,000$49.00$1,470,000.00  
(Data available from 1/1/2013 forward)

KYMR Insider Trading Activity - Frequently Asked Questions

The list of insiders at Kymera Therapeutics includes Bros. Advisors Lp Baker, Bruce Booth, Bruce N Jacobs, Bvf Partners L P/Il, Elena Ridloff, Ellen Chiniara, Jared Gollob, Jeffrey W Albers, Jeremy G Chadwick, Joanna Horobin, Nello Mainolfi, Noah Goodman, Pamela Esposito, and Venture Fund X L.P. Atlas. Learn more on insiders at KYMR.

15.98% of Kymera Therapeutics stock is owned by insiders. Learn more on KYMR's insider holdings.

The following insiders have purchased KYMR shares in the last 24 months: Bros. Advisors Lp Baker ($201,341,918.00), and Bvf Partners L P/Il ($13,955,348.00).

Insiders have purchased a total of 2,978,480 KYMR shares in the last 24 months for a total of $215,297,266.00 bought.

The following insiders have sold KYMR shares in the last 24 months: Bruce Booth ($48,410,836.83), Bruce N Jacobs ($5,266,492.93), Elena Ridloff ($1,577,870.00), Ellen Chiniara ($198,874.20), Jared Gollob ($10,195,029.65), Jeffrey W Albers ($744,750.00), Jeremy G Chadwick ($14,268,236.64), Joanna Horobin ($280,415.00), Nello Mainolfi ($21,171,700.00), Noah Goodman ($1,019,030.00), and Pamela Esposito ($651,780.00).

Insiders have sold a total of 1,591,521 Kymera Therapeutics shares in the last 24 months for a total of $104,341,616.25 sold.



This page (NASDAQ:KYMR) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners